1. Xu, Yuewei, Nijhuis, Anke, Keun, Hector C. 2021. RNA-binding motif protein 39 (RBM39): An emerging cancer target. In British journal of pharmacology, 179, 2795-2812. doi:10.1111/bph.15331. https://pubmed.ncbi.nlm.nih.gov/33238031/
2. Wang, Eric, Lu, Sydney X, Pastore, Alessandro, Abdel-Wahab, Omar, Aifantis, Iannis. 2019. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia. In Cancer cell, 35, 369-384.e7. doi:10.1016/j.ccell.2019.01.010. https://pubmed.ncbi.nlm.nih.gov/30799057/
3. Campagne, Sébastien, Jutzi, Daniel, Malard, Florian, Ruepp, Marc-David, Allain, Frédéric H-T. 2023. Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39. In Nature communications, 14, 5366. doi:10.1038/s41467-023-40254-5. https://pubmed.ncbi.nlm.nih.gov/37666821/
4. Pech, Matthew F, Fong, Linda E, Villalta, Jacqueline E, Jan, Calvin H, Settleman, Jeffrey. 2019. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. In eLife, 8, . doi:10.7554/eLife.47362. https://pubmed.ncbi.nlm.nih.gov/31452512/
5. Dong, Xiao, Han, Yang, Zhang, Encheng, Zhong, Lin, Li, Qi. 2021. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma. In Aging, 13, 10603-10618. doi:10.18632/aging.202823. https://pubmed.ncbi.nlm.nih.gov/33833131/
6. Ting, Tabitha C, Goralski, Maria, Klein, Katherine, Xie, Yang, Nijhawan, Deepak. . Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15. In Cell reports, 29, 1499-1510.e6. doi:10.1016/j.celrep.2019.09.079. https://pubmed.ncbi.nlm.nih.gov/31693891/
7. Xu, Yuewei, Spear, Sarah, Ma, Yurui, Keun, Hector C, Nijhuis, Anke. 2023. Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma. In Cell reports, 42, 113307. doi:10.1016/j.celrep.2023.113307. https://pubmed.ncbi.nlm.nih.gov/37858464/
8. Kohsaka, Shinji, Yagishita, Shigehiro, Shirai, Yukina, Hamada, Akinobu, Mano, Hiroyuki. 2024. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency. In NPJ precision oncology, 8, 117. doi:10.1038/s41698-024-00610-0. https://pubmed.ncbi.nlm.nih.gov/38789724/
9. Kim, Sung Ah, Jo, Seung-Hyun, Cho, Jin Hwa, Kim, Sunhong, Kim, Jeong-Hoon. . Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4DCAF15 E3 Ligase. In Molecules and cells, 43, 935-944. doi:10.14348/molcells.2020.0122. https://pubmed.ncbi.nlm.nih.gov/33168788/
10. Ji, Tongting, Yang, Yang, Yu, Juanjuan, Pan, Jian, Lu, Jun. 2024. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia. In Journal of experimental & clinical cancer research : CR, 43, 205. doi:10.1186/s13046-024-03130-8. https://pubmed.ncbi.nlm.nih.gov/39044280/
智鼠故事 
